Merck | MRK - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
AbbVie USD 4.28B 10M 2026-09
Abbott USD 6.47B 525M 2026-09
ALKERMES USD 120.7M 47.44M 2026-06
Amgen USD 1.87B 271M 2026-06
AstraZeneca USD 2.78B 260M 2026-09
Biogen USD 921.2M 23.9M 2026-09
Bristol-Myers Squibb USD 8.75B 861M 2026-09
Coherus Biosciences USD 4.04M 324K 2025-12
Drreddys Laboratories INR 41.5B 9.38B 2026-09
Eli Lilly USD 3.93B 665M 2026-09
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.23B 163M 2026-09
Glaxosmithkline GBP 2.39B 515M 2026-09
J&J USD 8.08B 80M 2026-09
Medtronic USD 3.83B 26M 2026-06
Merck USD 3.36B 212M 2026-09
Novartis USD 3.57B 137M 2026-09
Novartis USD 3.61B 149M 2026-09
Novo Nordisk DKK 17.1B 3.5B 2026-06
Pacira USD 58.49M 7.75M 2026-06
Perrigo USD 708.9M 65.2M 2026-06
Pfizer USD 4.09B 498M 2026-06
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 135.22M 5.54M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 4.19B 1.17B 2026-09
Sanofi EUR 3.02B 121M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
Zoetis USD 704M 32M 2026-06